JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB43821

Anti-Influenza A Virus Nucleoprotein antibody [9G8]

Be the first to review this product! Submit a review

|

(7 Publications)

Mouse Monoclonal NCAP antibody. Suitable for ELISA, WB, ICC/IF and reacts with Influenza A samples. Cited in 7 publications.

View Alternative Names

Nucleoprotein, Nucleocapsid protein, Protein N, NP

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

9G8

Isotype

IgG2a

Light chain type

kappa

Carrier free

No

Reacts with

Influenza A

Applications

WB, ICC/IF, ELISA

applications

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Influenza A": { "ELISA-species-checked": "guaranteed", "ELISA-species-dilution-info": "1/2000 - 1/10000", "ELISA-species-notes": "<p></p>", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "1/200 - 1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "1/100 - 1/500", "ICCIF-species-notes": "<p>On infected cells</p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
Constituents: 2% Sucrose, 1.21% Tris, 0.75% Glycine
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Influenza A Virus Nucleoprotein also known as NP or nucleoprotein influenza A plays a significant mechanical role in the virus life cycle. It is an essential structural component that encapsidates viral RNA forming ribonucleoprotein complexes important for replication and transcription. Influenza A nucleoprotein has a molecular weight of approximately 56 kDa and is expressed in infected host cells. Within the influenza virion the nucleoprotein interacts with the viral RNA and polymerase complex ensuring the integrity and functionality of the viral genome.
Biological function summary

The influenza A nucleoprotein is involved in regulating viral RNA synthesis and acts as a platform for the assembly of viral components. It does not directly form stable complexes with host proteins but it is central to the ribonucleoprotein complexes that are vital for the virus life cycle. This nucleoprotein assists in the virus's ability to hijack the host cellular machinery favoring its replication and infection processes. While the nucleoprotein itself does not form direct complexes with host proteins its interactions are significant for facilitating various stages of the viral life cycle.

Pathways

The influenza A nucleoprotein operates within the viral replication and transcription pathways. It associates with proteins such as PB1 PB2 and PA of the polymerase complex which is important for viral RNA synthesis. The nucleoprotein ensures the proper packaging of the viral genome to be recognized by the polymerase complex playing a pivotal role in the viral replication process. Through these pathways it indirectly impacts the host immune response as the virus must evade host defenses to ensure replication success.

The nucleoprotein influenza A is primarily linked to influenza infections a major respiratory illness. Influenza can manifest in a mild to severe form occasionally leading to pandemics. The nucleoprotein is an attractive target for antiviral drug development given its essential role in the viral life cycle. Moreover studies have shown that variations and mutations in the nucleoprotein can affect viral virulence and the outcome of infection. By understanding its mechanisms and interactions with other viral proteins like HA and NA researchers can better develop strategies to combat influenza outbreaks.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Encapsidates the negative strand viral RNA, protecting it from nucleases. The encapsidated genomic RNA is termed the ribonucleoprotein (RNP) and serves as template for transcription and replication. The RNP needs to be localized in the host nucleus to start an infectious cycle, but is too large to diffuse through the nuclear pore complex. NP comprises at least 2 nuclear localization signals that are responsible for the active RNP import into the nucleus through cellular importin alpha/beta pathway. Later in the infection, nclear export of RNPs are mediated through viral proteins NEP interacting with M1 which binds nucleoproteins. It is possible that nucleoprotein binds directly host exportin-1/XPO1 and plays an active role in RNPs nuclear export. M1 interaction with RNP seems to hide nucleoprotein's nuclear localization signals. Soon after a virion infects a new cell, M1 dissociates from the RNP under acidification of the virion driven by M2 protein. Dissociation of M1 from RNP unmasks nucleoprotein's nuclear localization signals, targeting the RNP to the nucleus.
See full target information NP

Publications (7)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in immunology 13:827760 PubMed35359920

2022

Effects of Receptor Specificity and Conformational Stability of Influenza A Virus Hemagglutinin on Infection and Activation of Different Cell Types in Human PBMCs.

Applications

Unspecified application

Species

Unspecified reactive species

Jens Dorna,Andreas Kaufmann,Viktoria Bockmann,Hartmann Raifer,Johanna West,Mikhail Matrosovich,Stefan Bauer

PLoS pathogens 17:e1009321 PubMed34473799

2021

Rab11a mediates cell-cell spread and reassortment of influenza A virus genomes via tunneling nanotubes.

Applications

Unspecified application

Species

Unspecified reactive species

Ketaki Ganti,Julianna Han,Balaji Manicassamy,Anice C Lowen

Nature microbiology 5:1158-1169 PubMed32632248

2020

Collective interactions augment influenza A virus replication in a host-dependent manner.

Applications

Unspecified application

Species

Unspecified reactive species

Kara L Phipps,Ketaki Ganti,Nathan T Jacobs,Chung-Young Lee,Silvia Carnaccini,Maria C White,Miglena Manandhar,Brett E Pickett,Gene S Tan,Lucas M Ferreri,Daniel R Perez,Anice C Lowen

The Journal of biological chemistry 295:11388-11407 PubMed32303635

2020

Transcriptome profiling and protease inhibition experiments identify proteases that activate H3N2 influenza A and influenza B viruses in murine airways.

Applications

Unspecified application

Species

Unspecified reactive species

Anne Harbig,Marco Mernberger,Linda Bittel,Stephan Pleschka,Klaus Schughart,Torsten Steinmetzer,Thorsten Stiewe,Andrea Nist,Eva Böttcher-Friebertshäuser

PloS one 8:e75005 PubMed24137500

2013

Sphingosine kinase 1 serves as a pro-viral factor by regulating viral RNA synthesis and nuclear export of viral ribonucleoprotein complex upon influenza virus infection.

Applications

WB

Species

Unspecified reactive species

Young-Jin Seo,Curtis J Pritzl,Madhuvanthi Vijayan,Kavita Bomb,Mariah E McClain,Stephen Alexander,Bumsuk Hahm

Antiviral research 96:376-85 PubMed23041142

2012

Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir.

Applications

Unspecified application

Species

Unspecified reactive species

Nigel J Dimmock,Brian K Dove,Bo Meng,Paul D Scott,Irene Taylor,Linda Cheung,Bassam Hallis,Anthony C Marriott,Miles W Carroll,Andrew J Easton

Health technology assessment (Winchester, England) 14:237-354 PubMed20923613

2010

Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings.

Applications

Unspecified application

Species

Unspecified reactive species

B Killingley,J Greatorex,S Cauchemez,J E Enstone,M Curran,R C Read,W S Lim,A Hayward,K G Nicholson,J S Nguyen-Van-Tam
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com